The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

64 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Improved Potency of Indole-Based NorA Efflux Pump Inhibitors: From Serendipity toward Rational Design and Development.EBI
University of Perugia
Metabolism study and biological evaluation of bosentan derivatives.EBI
University of Perugia
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics.EBI
University of Perugia
Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism.EBI
University of Perugia
Indole Based Weapons to Fight Antibiotic Resistance: A Structure-Activity Relationship Study.EBI
University of Perugia
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands.EBI
University of Perugia
One-pot heterogeneous synthesis of¿(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.EBI
University of Perugia
Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.EBI
University of Perugia
Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors.EBI
University of Perugia
Probing the Binding Site of Bile Acids in TGR5.EBI
University of Perugia
Asymmetric synthesis of the four diastereoisomers of a novel non-steroidal farnesoid X receptor (FXR) agonist: role of the chirality on the biological activity.EBI
University of Perugia
Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.EBI
University of Perugia
Comparison of ligand-based and structure-based 3D-QSAR approaches: a case study on (aryl-)bridged 2-aminobenzonitriles inhibiting HIV-1 reverse transcriptase.EBI
University of Perugia
Inhibitor of ovarian cancer cells growth by virtual screening: a new thiazole derivative targeting human thymidylate synthase.EBI
University of Perugia
Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors.EBI
University of Perugia
Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonists.EBI
University of Perugia
Synthesis and biological affinity of new imidazo- and indol-arylpiperazine derivatives: further validation of a pharmacophore model for alpha(1)-adrenoceptor antagonists.EBI
University of Perugia
Synthesis and characterization of carnitine nitro-derivatives.EBI
University of Perugia
Synthesis, molecular modeling studies, and preliminary pharmacological characterization of all possible 2-(2'-sulfonocyclopropyl)glycine stereoisomers as conformationally constrained L-homocysteic acid analogs.EBI
University of Perugia
Synthesis and preliminary pharmacological evaluation of the four stereoisomers of (2S)-2-(2'-phosphono-3'-phenylcyclopropyl)glycine, the first class of 3'-substituted trans C1'-2'-2-(2'-phosphonocyclopropyl)glycines.EBI
University of Perugia
Back door modulation of the farnesoid X receptor: design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives.EBI
University of Perugia
Synthesis and preliminary biological evaluation of (2S,1'R,2'S)- and (2S,1'S,2'R)-2-(2'-phosphonocyclopropyl)glycines, two novel conformationally constrained l-AP4 analogues.EBI
University of Perugia
Is antagonism of E/Z-guggulsterone at the farnesoid X receptor mediated by a noncanonical binding site? A molecular modeling study.EBI
University of Perugia
Farnesoid X receptor: from structure to potential clinical applications.EBI
University of Perugia
Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid.EBI
University of Perugia
Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships.EBI
University of Perugia
Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase.EBI
University of Perugia
Binding mode of 6ECDCA, a potent bile acid agonist of the farnesoid X receptor (FXR).EBI
University of Perugia
Design, synthesis and preliminary evaluation of novel 3'-substituted carboxycyclopropylglycines as antagonists at group 2 metabotropic glutamate receptors.EBI
University of Perugia
A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.EBI
University of Perugia
Extending SAR of bile acids as FXR ligands: discovery of 23-N-(carbocinnamyloxy)-3a,7a-dihydroxy-6a-ethyl-24-nor-5β-cholan-23-amine.EBI
University of Perugia
Inhibitors of ABCG2-mediated multidrug resistance: Lead generation through computer-aided drug design.EBI
University of Perugia
Virtual screening for novel openers of pancreatic K(ATP) channels.EBI
University of Perugia
Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy.EBI
University of Perugia
Development of 3α,7α-dihydroxy-6α-ethyl-24-nor-5β-cholan-23-sulfate sodium salt (INT-767): Process optimization, synthesis and characterization of metabolites.EBI
University of Perugia
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1.EBI
University of Perugia
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity.EBI
University of Perugia
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.EBI
University of Perugia
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15.EBI
University of Perugia
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors.EBI
University of Perugia
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors.EBI
University of Perugia
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase.EBI
University of Perugia
Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs.EBI
University of Perugia
The Medicinal Chemistry in the Era of Machines and Automation: Recent Advances in Continuous Flow Technology.EBI
University of Perugia
Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X Receptor.EBI
University of Perugia
Exploiting Chemical Toolboxes for the Expedited Generation of Tetracyclic Quinolines as a Novel Class of PXR Agonists.EBI
University of Perugia
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation.EBI
University of Perugia
Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs).EBI
University of Perugia
Scaffold hopping approach on the route to selective tankyrase inhibitors.EBI
University of Perugia
New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors.EBI
University of Perugia
Discovery of novel and cardioselective diltiazem-like calcium channel blockers via virtual screening.EBI
University of Perugia
Calcium channel antagonists discovered by a multidisciplinary approach.EBI
University of Perugia
GBR compounds and mepyramines as cocaine abuse therapeutics: chemometric studies on selectivity using grid independent descriptors (GRIND).EBI
University of Perugia
Synthesis, biological evaluation, and pharmacophore generation of new pyridazinone derivatives with affinity toward alpha(1)- and alpha(2)-adrenoceptors.EBI
University of Perugia
GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors.EBI
University of Perugia
Potent 6-desfluoro-8-methylquinolones as new lead compounds in antibacterial chemotherapy.EBI
University of Perugia
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.EBI
University of Perugia
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors.EBI
University of Perugia
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase.EBI
University of Perugia
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position.EBI
University of Perugia
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.EBI
University of Perugia
Synthesis, physicochemical properties, and biological activity of bile acids 3-glucuronides: Novel insights into bile acid signalling and detoxification.EBI
University of Perugia
Fragment-based approach to identify IDO1 inhibitor building blocks.EBI
University of Perugia
Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists.EBI
University of Perugia